이상반응 보고
VAERS ID | 907101 |
---|---|
성별 | 여성 |
나이 | 41세 |
주 코드 | ME |
제약회사 | PFIZER\BIONTECH |
로트 번호 | EL1284 |
예방접종 횟수 | 1 |
접종일 | 2020-12-22 |
발병일 | 2020-12-22 |
상태 | 입원 중증 회복 |
증상
- 다한증(Hyperhidrosis)
- 메스꺼움(Nausea)
- 두근거림(Palpitations)
- 기침(Cough)
- 흉부 엑스레이(Chest X-ray)
- 언어 장애(Speech disorder)
이환 중 질병
had been feeling slightly under the weather two weeks ago; no current asthma exacerbation, but has very labile asthma
지병
Sleep apnea on CPAP eosinophilic asthma on multiple controller meds environmental allergies obesity
기타 의료
SIngulair, advair, Duonebs, dupixent, albuterol, zyrtec, chlorpheniramine; wellbutrin, Sertraline;
이전 예방접종
알레르기
Anaphylaxis hx to NSAIDS; hs of environmental allergies, and reaction to latex
임상 검사
12/22/20 - CXR ordered - results not currently available
증상 상세
patient felt slightly nauseated at 10 minutes after injection, then developed slight sweating; BP 160/81; 83 at 5:45 and then 158/87 with HR 82 at 5: 52 pm.
Her lungs were clear, she was speaking in full sentences and was denying any chest pressure, her usual sense of asthma exacerbation.
At 6:05 it was 164/83 with HR 79 and patient developed a dry cough; we decided to have her wait just a bit longer, then cough worsened, so at 6:25, decision was made to have patient seen in ER for further assessment, and en route in wheelchair to ER the dry cough became persistent, spasmodic and patient was unable to speak.
Epi-Pen was injected in right mid thigh, and patient transported to ED urgent eval.
She noted immediate palpitations, and slight improvement of breahting, was able to speak in four word sentences.
On arrival to the ED, patient was administered Duonebs, Albuterol neb, IV Benedryl, IV Solumedrol; CXR was obtained, with results pending.
Patient was sent to observation for ongoing monitoring and assessment of breathing.
at 6:30 PM in the ER, she